跳至主要内容
临床试验/NCT07133711
NCT07133711已完成不适用

Impact of Noninvasive Ventilation Weaning Protocol on Outcome of Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Assiut University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Successful weaning

研究概览

简要总结

Noninvasive ventilation (NIV) has revolutionized the management of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) with hypercapnic respiratory failure (HcRF). NIV use has been shown to reduce the need for endotracheal intubation, hospital and intensive care unit (ICU) length of stay, and mortality.

Multiple studies have been conducted on weaning strategies among patients requiring invasive mechanical ventilation. As a result of these studies, definite criteria and protocols have been laid down for weaning from invasive mechanical ventilation. However, no such data are available for the withdrawal of NIV.

Evidence-based reviews suggest that protocols to manage the weaning and liberation of subjects from Mechanical Ventilation could reduce the time that subjects spend receiving mechanical ventilation. However, no such data about protocolized withdrawal of NIV are available.

详细描述

A study to compare protocolized weaning from non-invasive ventilation using three potential strategies of weaning from NIV

  • Stepwise reduction of duration of NIV use,
  • Stepwise reduction in pressure support of NIV, and
  • Immediate withdrawal of NIV. Among patients with Acute respiratory failure due to acute exacerbation of COPD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Due to the nature of the interventions, participants and clinical staff managing the weaning will not be blinded to group assignment. However, outcome assessors [the physician adjudicating weaning success based on predefined criteria] and data analysts will be blinded to group allocation throughout the outcome assessment and analysis phases

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •All COPD patients admitted in the respiratory ICU with acute Hypercapnic Respiratory Failure who will be managed with Noninvasive Ventilation without the need for invasive mechanical ventilation will be eligible for inclusion in the study.

排除标准

  • •Age: less than 18 years,
  • •End organ failure as cardiac/ Liver/ Renal,
  • •Patients on home NIV and
  • •Those who required NIV for respiratory failure due to diseases other than COPD were not considered for the study.

研究组 & 干预措施

Gradual PS Decrement

Experimental

): pressure support will be reduced by 2-4 cm H2O every 6-8 h with vitals and blood gas monitoring till IPAP of <8 cm of H2O and EPAP of <4 cm of H2O is attained, after which NIV will be completely withdrawn

干预措施: Noninvasive ventilation (Device)

Gradual Time Decrement

Experimental

the duration of NIV will be reduced to 16 h on the day of randomization (day 0), then reduced to 12 h on day 1 (including 6-8 h of overnight use), 6-8 h of overnight use on day 2, and complete withdrawal on day 3.

干预措施: Noninvasive ventilation (Device)

Abrupt Withdrawal

Active Comparator

patients will be immediately withdrawn from NIV and monitored on spontaneous breathing.

干预措施: Noninvasive ventilation (Device)

结局指标

主要结局

Successful weaning

时间窗: 48 hours

The primary objective of the study is to compare the rate of successful withdrawal of NIV among the three groups.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Waleed Gamal Elddin Khaleel

Assistant professor of chest diseases

Assiut University

研究点 (1)

Loading locations...

相似试验